Rosiglitazone Inhibits Bone Regeneration and Causes Significant Accumulation of Fat at Sites of New Bone Formation

Thiazolidinediones (TZDs), peroxisome proliferator-activated receptor gamma activators, and insulin sensitizers represent drugs used to treat hyperglycemia in diabetic patients. Type 2 diabetes mellitus (T2DM) is associated with a twofold increase in fracture risk, and TZDs use increases this risk b...

Full description

Saved in:
Bibliographic Details
Main Authors: Liu, Lichu, Aronson, James, Huang, Shilong, Lu, Yalin, Czernik, Piotr, Rahman, Sima, Kolli, Vipula, Suva, Larry J., Lecka-Czernik, Beata
Format: Artigo
Language:Inglês
Published: 2012
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3630993/
https://ncbi.nlm.nih.gov/pubmed/22752619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00223-012-9623-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items